Skip to content

Advertisement

Open Access

Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

  • John Greenwood1,
  • Margareta Hammarlund-Udenaes2,
  • Hazel C. Jones3Email author,
  • Alan W. Stitt4,
  • Roosmarijn E. Vandenbroucke5, 6,
  • Ignacio A. Romero7,
  • Matthew Campbell8,
  • Gert Fricker9,
  • Birger Brodin10,
  • Heiko Manninga11,
  • Pieter J. Gaillard12,
  • Markus Schwaninger13,
  • Carl Webster14,
  • Krzysztof B. Wicher15 and
  • Michel Khrestchatisky16, 17
Fluids and Barriers of the CNS201815:3

https://doi.org/10.1186/s12987-017-0086-x

Received: 8 December 2017

Accepted: 12 December 2017

Published: 12 January 2018

The original article was published in Fluids and Barriers of the CNS 2017 14:31

Correction to: Fluids Barriers CNS (2017) 14:31 https://doi.org/10.1186/s12987-017-0079-9

After publication of the article [1], it has been brought to our attention that there are some errors in the formatting of names in the final version of the article.

Firstly, the article’s fifth author had their name spelt incorrectly. Previously included as “Roosmarijn E. Vandenbrouke”, the correct spelling is “Roosmarijn E. Vandenbroucke”. This error was present in the author list and page 3 of the article.

Furthermore, author names in the article references had formatting issues. This occurred in cases where “van” is part of the naming structure. In these cases the rest of the last name was included incorrectly as an initial. The references affected are listed below with their corrected author list.
  • Reference #7 should read: Vandenbroucke RE, Dejonckheere E, Van Lint P, Demeestere D, Van Wonterghem E, Vanlaere I, et al.

  • Reference #8 should read: Brkic M, Balusu S, Van Wonterghem E, Gorlé N, Benilova I, Kremer A, et al.

  • Reference #9 should read: Balusu S, Van Wonterghem E, De Rycke R, Raemdonck K, Stremersch S, Gevaert K, et al.

  • Reference #10 should read: Reijerkerk A, Lopez-Ramirez MA, van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, et al.

  • Reference #22 should read: Loryan I, Sinha V, Mackie C, Van Peer A, Drinkenburg W, Vermeulen A, et al.

Notes

Declarations

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Institute of Ophthalmology, University College London, London, UK
(2)
Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
(3)
Gagle Brook House, Chesterton, Bicester, UK
(4)
Centre for Experimental Medicine, Queen’s University Belfast, Belfast, UK
(5)
Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium
(6)
VIB-UGent Center for Inflammation Research, VIB, Ghent, Belgium
(7)
School of Life, Health and Chemical Sciences, Open University, Milton Keynes, UK
(8)
Smurfit Institute of Genetics, Lincoln Place Gate, Trinity College Dublin, Dublin 2, Ireland
(9)
Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls University, Heidelberg, Germany
(10)
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
(11)
NEUWAY Pharma GmbH, Bonn, Germany
(12)
2-BBB Medicines BV, Leiden, Netherlands
(13)
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany
(14)
Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK
(15)
Ossianix Inc., Stevenage, UK
(16)
CNRS, NICN, Aix Marseille Univ, Marseille, France
(17)
Vect-Horus, Marseille, France

Reference

  1. Greenwood J, Hammarlund-Udenaes M, Jones HC, Stitt AW, Vandenbroucke RE, Romero IA, Campbell M, Fricker G, Brodin B, Manninga H, Gaillard PJ, Schwaninger M, Webster C, Wicher KB, Khrestchatisky M. Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017. Fluids Barriers CNS. 2017;14:31. https://doi.org/10.1186/s12987-017-0079-9.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s) 2017

Advertisement